右美托咪定
医学
镇静
咪唑安定
异丙酚
镇静剂
水合氯醛
自闭症谱系障碍
麻醉
自闭症
荟萃分析
不利影响
重症监护医学
精神科
药理学
内科学
作者
Luisa Zupin,Cyril Sahyoun,Baruch Krauss,Arianna Dagri,Elisabetta Maria Rocco,Egidio Barbi,Fulvio Celsi
摘要
Abstract Aim Management of primary healthcare and routine minor procedures for children with autism spectrum disorder (ASD) can be challenging; therefore, when behavioural strategies fail, sedative medications are often employed. We evaluated the effectiveness of the current pharmacological strategies for managing children with ASD. Methods We performed a systematic review and meta‐analysis of the current approaches for procedural sedation in children with ASD. Results Twenty studies met inclusion criteria. Dexmedetomidine, midazolam, propofol and chloral hydrate were the most efficient agents for successful procedures, while propofol had the highest number of adverse events. The most frequently used agents were dexmedetomidine and midazolam or a combination of the two, and the effectiveness of dexmedetomidine plus midazolam was superior to dexmedetomidine alone. Conclusion Multiple effective drug regimens exist for procedural sedation in children with ASD. These results could support the development of specific guidelines for procedural sedation in children with ASD.
科研通智能强力驱动
Strongly Powered by AbleSci AI